Latest News

Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study. These findings could be the first step toward developing new interventions for PTSD.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Nicotine use increases compulsive alcohol consumption, study finds

  • Major vascular anomalies found in brains of people with Huntington's disease

  • Cancer and chemobrain: Cancer diagnosis affects cognitive function

  • Epilepsy drug may preserve eyesight for people with multiple sclerosis

  • Should they stay or should they go? Study finds no harm from hospital policies that let families observe CPR

  • Difficult to break the soda habit? Sugar-sweetened beverages suppress body's stress response

  • Electronic micropump to deliver treatments deep within the brain

  • Increasing evidence points to inflammation as source of nervous system manifestations of Lyme disease

  • Scientists use brain stimulation to boost creativity, set stage to potentially treat depression

  • Botox makes unnerving journey into our nervous system

  •